Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
327.2 INR | +0.03% | -1.99% | -19.41% |
03-19 | Venus Remedies Secures Marketing Authorizations in Ukraine for Three Oncology Drugs | MT |
03-08 | Venus Remedies Gets Ukraine's Marketing Approval for Three Oncology Products | MT |
Sales 2022 | 5.99B 71.74M 5.74B | Sales 2023 | 5.56B 66.57M 5.33B | Capitalization | 2.16B 25.94M 2.08B |
---|---|---|---|---|---|
Net income 2022 | 407M 4.88M 390M | Net income 2023 | 266M 3.19M 255M | EV / Sales 2022 | 0.6 x |
Net cash position 2022 | 4.11M 49.2K 3.94M | Net cash position 2023 | 291M 3.48M 279M | EV / Sales 2023 | 0.34 x |
P/E ratio 2022 |
8.71
x | P/E ratio 2023 |
8.15
x | Employees | 998 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 52.79% |
1 day | +0.03% | ||
1 week | -1.99% | ||
Current month | +0.23% | ||
1 month | +0.23% | ||
3 months | -11.95% | ||
6 months | +20.28% | ||
Current year | -19.41% |
Managers | Title | Age | Since |
---|---|---|---|
Ashutosh Jain
CEO | Chief Executive Officer | 46 | 30/04/07 |
Pawan Chaudhary
CHM | Chairman | 59 | 14/09/89 |
Jitendra Singh
ADM | Chief Administrative Officer | - | 31/12/98 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gilbert Wenzel
BRD | Director/Board Member | 67 | - |
Peeyush Jain
BRD | Director/Board Member | 52 | - |
Ashutosh Jain
CEO | Chief Executive Officer | 46 | 30/04/07 |
Date | Price | Change | Volume |
---|---|---|---|
30/04/24 | 327.2 | +0.03% | 3 401 |
29/04/24 | 327 | -0.38% | 2,310 |
26/04/24 | 328.3 | +0.14% | 1,500 |
25/04/24 | 327.8 | -0.65% | 2,847 |
24/04/24 | 330 | -0.23% | 3,314 |
Delayed Quote Bombay S.E., April 30, 2024 at 11:00 am
More quotes1st Jan change | Capi. | |
---|---|---|
-19.41% | 52.39M | |
+33.38% | 664B | |
+29.29% | 567B | |
-7.18% | 354B | |
+19.13% | 330B | |
+4.74% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.73% | 148B |
- Stock Market
- Equities
- VENUSREM Stock